Century Therapeutics Inc (IPSC)
2.99
-0.14
(-4.47%)
USD |
NASDAQ |
May 17, 16:00
2.99
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Total Liabilities (Quarterly): 170.62M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 170.62M |
| December 31, 2023 | 175.94M |
| September 30, 2023 | 178.32M |
| June 30, 2023 | 169.59M |
| March 31, 2023 | 179.05M |
| December 31, 2022 | 183.81M |
| September 30, 2022 | 181.55M |
| Date | Value |
|---|---|
| June 30, 2022 | 174.63M |
| March 31, 2022 | 163.64M |
| December 31, 2021 | 41.14M |
| September 30, 2021 | 46.74M |
| June 30, 2021 | 48.03M |
| March 31, 2021 | 377.61M |
| December 31, 2020 | 213.19M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
41.14M
Minimum
Dec 2021
377.61M
Maximum
Mar 2021
164.56M
Average
175.29M
Median
Total Liabilities (Quarterly) Benchmarks
| Verastem Inc | 77.32M |
| Entero Therapeutics Inc | 3.280M |
| Gritstone Bio Inc | 123.25M |
| Allogene Therapeutics Inc | 124.98M |
| Mirum Pharmaceuticals Inc | 417.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 348.51M |
| Shareholders Equity (Quarterly) | 177.88M |
| Current Ratio | 12.44 |
| Net Debt Paydown Yield | 0.76% |